This is not surprising, since many studies have revealed the role of DVL3 in the pathogenesis and prognosis of different types of tumors, including colorectal cancer [36], liver cancer [37], lung adenocarcinoma [38], pancreatic adenocarcinoma [39], and prostate cancer [40]. The gene discussed is DVL3; the disease is prostate carcinoma.